Search results for "bowel"

showing 10 items of 637 documents

Systemic schistosomiasis and large bowel perforation: An unexpected surgical urgency. Report of a case and literature review

2019

Key Clinical Message In the presence of suggestive clinical picture (high eosinophil count and multiple CT scan granuloma‐like lesions), schistosomiasis should be taken into account in case of suspected bowel perforation even if common risk factors are not identified through anamnesis.

Anamnesismedicine.medical_specialtyHigh eosinophil countmedicine.diagnostic_testbusiness.industryCase ReportSchistosomiasisComputed tomographyCase ReportsGeneral MedicineBowel perforation030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineEmergency surgery030220 oncology & carcinogenesiscolonic perforationMedicineRadiologyemergency surgerysystemic schistosomiasisbusinessClinical Case Reports
researchProduct

Microsporidia and Its Relation to Crohn's Disease. A Retrospective Study

2013

Background: The cause of Crohn's Disease (CD) remains unknown. Recently a decrease in the global lymphocyte population in the peripheral blood of CD patients has been reported. This decrease was more evident in gamma delta T lymphocytes, especially gamma delta CD8+T subsets. Furthermore, a decrease of IL-7 was also observed in these patients. We propose the hypothesis that microsporidia, an obligate intracellular opportunistic parasite recently related to fungi, in CD patients can take advantage of the lymphocytes and IL-7 deficits to proliferate and to contribute to the pathophysiology of this disease. Methods and Findings: In this case-control study, serum samples were collected from 36 C…

Anatomy and PhysiologyNon-Clinical MedicineLymphocytePopulationlcsh:MedicineDiseaseGastroenterology and HepatologyBiologyReal-Time Polymerase Chain ReactionBiochemistryAntibodiesCrohn DiseaseT-Lymphocyte SubsetsImmune PhysiologyMicrosporidiosismedicineParasitic DiseasesCytotoxic T cellHumanslcsh:ScienceeducationBiologyRetrospective Studieseducation.field_of_studyCrohn's diseaseMultidisciplinaryHealth Care Policylcsh:RInflammatory Bowel DiseaseCase-control studyFungal DiseasesHealth Risk AnalysisEncephalitozoonImmunoglobulin Emedicine.diseaseVirologyPathophysiologymedicine.anatomical_structureInfectious DiseasesCase-Control StudiesImmunologyBlood ChemistryMicrosporidiaMedicinelcsh:QCD8Research Article
researchProduct

Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: A…

2000

Bowel obstruction may be an inoperable complication in patients with end-stage cancer. Scopolamine butylbromide (SB) and octreotide (OCT) have been successfully used with the aim of reducing gastrointestinal (GI) secretions to avoid placement of a nasogastric tube (NGT); however, there have been no comparative studies concerning the efficacy of these drugs. Furthermore, there is little information about the role played by parenteral hydration in symptom control of these patients. In a prospective trial that involved all 17 inoperable bowel-obstructed patients presenting to our services with a decompressive NGT, patients were randomized to OCT 0.3 mg/day or SB 60 mg/day for 3 days through a …

Anesthesiology and Pain MedicineScopolamine butylbromideHydrationNeurology (clinical)OctreotideNursing (all)2901 Nursing (miscellaneous)Bowel obstructionCancer
researchProduct

Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids

2021

Abstract Background Irritable bowel syndrome (IBS) is a functional bowel disorder, in which recurrent abdominal pain is associated with defecation or a change in bowel habits. STW 5-II is a combination of six medicinal herbs with a clinically proven efficacy in managing IBS. Aim This study aims to establish an in vitro IBS model using mouse intestinal organoids and to explore the anti-inflammatory and tight junction protective activities of the multi-herbal preparation STW 5-II. Methods Intestinal organoids were cultured in 1:1 Matrigel™ and medium domes. Inflammation and tight junction disruption were induced by a cocktail of cytokines (TNFα, IFNγ, IL-1β, IL-6) and bacterial proteins (LPS,…

Anti-Inflammatory AgentsPharmaceutical ScienceInflammationPharmacologyTight JunctionsProinflammatory cytokineIrritable Bowel SyndromeMice03 medical and health sciencesOrgan Culture Techniques0302 clinical medicineWestern blotDownregulation and upregulationDrug DiscoverymedicineOrganoidAnimalsComputer SimulationIntestinal MucosaIrritable bowel syndrome030304 developmental biologyPharmacology0303 health sciencesTight junctionmedicine.diagnostic_testPlant Extractsbusiness.industryNF-kappa Bmedicine.diseaseIntestinesOrganoidsDisease Models AnimalSTAT1 Transcription FactorGene Expression RegulationComplementary and alternative medicine030220 oncology & carcinogenesisZonula Occludens-1 ProteinMolecular MedicineTumor necrosis factor alphaInflammation Mediatorsmedicine.symptombusinessPhytomedicine
researchProduct

APHAMAX® ATTENUATES INFLAMMATORY AND OXIDATIVE STRESS IN 2, 4-DINITROBENZENE SULFONIC ACID-INDUCED COLITIS IN RAT AMELIORATING INTESTINAL FUNCTIONALI…

2021

Accumulating evidences indicate that inflammatory and oxidative stress play an essential role in the pathogenesis and progression of inflammatory bowel disease (IBD). In IBD the excessive production of reactive oxygen species (ROS) and nitrogen metabolites contribute to tissue injury and could have also a profound impact on gut functions, including motility. We characterised the inflammatory and oxidative condition and the impact on colon motility in an experimental rat model of colitis, the 2, 4-dinitrobenzene sulfonic acid (DNBS)- induced colitis, and we evaluated if oral treatment with a nat- ural extract of Aphanizomenon flos-aquae (AFA) AphaMax®, containing concentrated quantity of AFA…

Aphamax Inflammatory bowel disease colon motilitySettore BIO/09 - Fisiologia
researchProduct

Genetics and novel aspects of therapies in systemic lupus erythematosus.

2015

Autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, autoimmune hepatitis and inflammatory bowel disease, have complex pathogeneses and the factors which cause these disorders are not well understood. But all have in common that they arise from a dysfunction of the immune system, interpreting self components as foreign antigens. Systemic lupus erythematosus (SLE) is one of these complex inflammatory disorders that mainly affects women and can lead to inflammation and severe damage of virtually any tissue and organ. Recently, the application of advanced techniques of genome-wide scanning revealed more genetic information about SLE than previously possible. These case-contro…

Autoimmune diseaseMultiple sclerosisImmunologyGenome-wide association studyAutoimmune hepatitisBiologymedicine.diseaseInflammatory bowel diseaseImmune systemAutologous stem-cell transplantationTreatment OutcomeRheumatoid arthritisHistocompatibility AntigensImmunologymedicineImmunology and AllergyAnimalsHumansLupus Erythematosus SystemicGenetic Predisposition to Diseaseskin and connective tissue diseasesImmunosuppressive AgentsGenome-Wide Association StudyAutoimmunity reviews
researchProduct

La preparazione intestinale alla colonscopia. Esperienza personale e breve review della letteraura

2007

BOWEL PREPARATION BEFORE COLONOSCOPY: PERSONAL EXPERIENCE AND BRIEF LITERATURE REVIEW
researchProduct

Laboratory Tests in Crohn’s Disease

2015

Laboratory tests are useful for diagnosing Crohn’s disease, assessing disease activity, identifying complications, and monitoring response to therapy. Their role has been considered limited in the past due to lack of specificity. The introduction of biological therapies in inflammatory bowel disease (IBD) has renewed interest in inflammatory markers, especially C-reactive protein (CRP), given their potential to select responders to these treatments. There are several reasons why laboratory markers have been studied in IBD in the past decades: firstly, to gain an objective measurement of disease activity as symptoms are often subjective; secondly, to avoid invasive (endoscopic) procedures wh…

Biological therapiesCrohn's diseasemedicine.medical_specialtyResponse to therapybusiness.industryObjective measurementDiseasemedicine.diseaseIron sucroseInflammatory bowel diseasemedicineIntensive care medicinebusinessIrritable bowel syndromemedicine.drug
researchProduct

Psychopharmacology treatment and psychological interventions in irritable bowel syndromel

2013

Irritable bowel syndrome (IBS) accounts for 25% of gastroenterology output practice, making it one of the most common disorders in this practice. Psychological and social factors may affect the development of this chronic disorder. Furthermore, psychiatric symptoms and psychiatric diseases are highly prevalent in this condition, but the approach to treating these is not always straightforward. As emphasized in the biopsychosocial model of IBS, with regard to the modulatory role of stress-related brain-gut interactions and association of the disease with psychological factors and emotional state, it proves useful to encourage psychopharmacological treatments and psychosocial therapies, both …

Biopsychosocial modelmedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologyAlternative medicinePsychological interventionDiseaseReview ArticleAffect (psychology)medicine.diseaseChronic disorderspsychopharmacological treatment. psychological interventions. irritable bowel diseasemedicinelcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869PsychiatrybusinessPsychosocialIrritable bowel syndrome
researchProduct

Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease Patients

2020

Inflammatory bowel disease (IBD) is a chronic, relapsing noninfectious inflammatory condition of the intestinal tract with two main phenotypes, ulcerative colitis (UC) and Crohn's disease (CD), and globally increasing incidence and prevalence. Nearly 80% of the IBD patients with active disease and 50% of those with inactive disease suffer fatigue with significant impairment of their quality of life. Fatigue has been associated with multiple factors in IBD patients but, in most cases, no direct cause can be identified, and risk factors in clinically quiescent IBD are contradictory. Furthermore, as the assessment of fatigue is subjective, there is an unmet clinical need for fatigue biomarkers…

BioquímicaBiologiamedicine.medical_specialtyDiseaseBiochemistryInflammatory bowel diseaseGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineLipidomicsmedicineHumansFatigue030304 developmental biology0303 health sciencesCrohn's diseasebusiness.industryIncidence (epidemiology)General ChemistryInflammatory Bowel Diseasesmedicine.diseaseSphingolipidUlcerative colitis3. Good health030220 oncology & carcinogenesisLipidomicsQuality of LifeColitis UlcerativebusinessSphingomyelinJournal of Proteome Research
researchProduct